## Abstract The data presented from the population‐based cancer registry in Harare, Zimbabwe, represent the first information on the incidence of cancer in a population of European origin living in Southern Africa for over 30 years. Their cancer pattern is more or less typical of white populations
Cancer in the african population of harare, Zimbabwe, 1990–1992
✍ Scribed by M. T. Bassett; E. Chokunonga; B. Mauchaza; L. Levy; J. Ferlay; D. M. Parkin
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 814 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The data presented from the population‐based cancer registry in Harare, Zimbabwe, represent the first information on the incidence of cancer in Southern Africa for almost 20 years. In the African population in Zimbabwe there are several features in common with other countries in sub‐Saharan Africa: high rates of liver, prostate and cervix cancer, low rates of large‐bowel cancer and breast cancer. Also, as reported from southern and south‐eastern Africa, there are relatively high incidence rates of cancers of the oesophagus, bladder and (in men) lung. The AIDS epidemic has given rise to a striking increase in incidence of Kaposi's sarcoma (now the commonest cancer of African men), but there is not much evidence for an increase in incidence of non‐Hodgkin lymphomas nor, although rates are very high, of cervical cancer.
📜 SIMILAR VOLUMES
## Abstract We describe breast cancer incidence and mortality in the predominantly African‐origin population of Barbados, which shares an ancestral origin with African‐Americans. Age‐standardized incidence rates were calculated from histologically confirmed breast cancer cases identified during a 4
## Abstract The effect of the evolving HIV epidemic on cancer has been sparsely documented in Africa. We report results on the risk of cancer associated with HIV‐1 infection using data from an ongoing study. A case–control analysis was used to estimate the relative risk (odds ratio, OR) of cancer t